Clinical significance of VEGF-C status in tumour cells and stromal macrophages in non-small cell lung cancer patients

[1]  K. Sugimachi,et al.  Clinical significance of vascular endothelial growth factor‐C (VEGF‐C) in breast cancer , 2001, Breast Cancer Research and Treatment.

[2]  J. Sleeman,et al.  Differential in vivo and in vitro expression of vascular endothelial growth factor (VEGF)-C and VEGF-D in tumors and its relationship to lymphatic metastasis in immunocompetent rats. , 2003, Cancer research.

[3]  S. Takeno,et al.  Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma , 2003, Cancer.

[4]  K. Alitalo,et al.  Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. , 2002, The American journal of pathology.

[5]  S. Takeno,et al.  VEGF-C expression correlates with histological differentiation and metastasis in squamous cell carcinoma of the esophagus. , 2002, Oncology reports.

[6]  Rakesh K Jain,et al.  Lymphatic Metastasis in the Absence of Functional Intratumor Lymphatics , 2002, Science.

[7]  H. Wada,et al.  Evaluation of angiogenesis in non-small cell lung cancer: comparison between anti-CD34 antibody and anti-CD105 antibody. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[8]  T. Ichikura,et al.  Prognostic significance of the expression of vascular endothelial growth factor (VEGF) and VEGF‐C in gastric carcinoma , 2001, Journal of surgical oncology.

[9]  K. Chayama,et al.  Clinicopathological significance of vascular endothelial growth factor (VEGF)‐C in human esophageal squamous cell carcinomas , 2001, International journal of cancer.

[10]  S. Eccles,et al.  Expression of vascular endothelial growth factor family members in head and neck squamous cell carcinoma correlates with lymph node metastasis , 2001, Cancer.

[11]  G. Watanabe,et al.  The expression of vascular endothelial growth factor C and its receptors in non-small cell lung cancer , 2001, British Journal of Cancer.

[12]  A. Hongo,et al.  Vascular endothelial growth factor-C expression and its relationship to pelvic lymph node status in invasive cervical cancer , 2001, British Journal of Cancer.

[13]  K. Sugiyama,et al.  Lymphangiogenesis and the vascular endothelial growth factor receptor (VEGFR)-3 in gastric cancer. , 2001, European journal of cancer.

[14]  M. Pepper,et al.  Lymphangiogenesis and tumor metastasis: myth or reality? , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[15]  L. Orci,et al.  Vascular endothelial growth factor‐C‐mediated lymphangiogenesis promotes tumour metastasis , 2001, The EMBO journal.

[16]  Y. Kakeji,et al.  Overexpression of Vascular Endothelial Growth Factor C Is Related to Lymphogenous Metastasis in Early Gastric Carcinoma , 2001, Oncology.

[17]  A. Nakagawara,et al.  Expression of vascular endothelial growth factors (VEGF-A/VEGF-1 and VEGF-C/VEGF-2) in postmenopausal uterine endometrial carcinoma. , 2001, Gynecologic oncology.

[18]  Seppo Ylä-Herttuala,et al.  Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3 , 2001, Nature Medicine.

[19]  Thomas Hawighorst,et al.  Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis , 2001, Nature Medicine.

[20]  H. Wada,et al.  Surgery for non-small cell lung cancer: postoperative survival based on the revised tumor-node-metastasis classification and its time trend. , 2000, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[21]  S. Hirohashi,et al.  Expression of vascular endothelial growth factors A, B, C, and D and their relationships to lymph node status in lung adenocarcinoma. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[22]  M. Oda,et al.  Increased vascular endothelial growth factor and vascular endothelial growth factor-c and decreased nm23 expression associated with microdissemination in the lymph nodes in stage I non-small cell lung cancer. , 2000, The Journal of thoracic and cardiovascular surgery.

[23]  M. Nomura,et al.  Placenta Growth Factor and Vascular Endothelial Growth Factor B and C Expression in Microvascular Endothelial Cells and Pericytes , 1999, The Journal of Biological Chemistry.

[24]  L. Mariani,et al.  Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features. , 1999, The American journal of pathology.

[25]  T. Obara,et al.  Vascular endothelial growth factor-C gene expression in papillary and follicular thyroid carcinomas. , 1999, Surgery.

[26]  H. Wada,et al.  Prognostic significance of apoptotic index in completely resected non-small-cell lung cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  Takuma Sasaki,et al.  Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[28]  Y. Shimosato,et al.  Histological Typing of Lung and Pleural Tumours , 1999, World Health Organization.

[29]  K. Alitalo,et al.  Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis , 1999, British Journal of Cancer.

[30]  W. Travis,et al.  Histological Classification of Lung and Pleural Tumours , 1999 .

[31]  K. Alitalo,et al.  Vascular endothelial growth factor C induces angiogenesis in vivo. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[32]  C. Mountain,et al.  Revisions in the International System for Staging Lung Cancer. , 1997, Chest.

[33]  S. Chevret,et al.  Blood vessel and lymphatic vessel invasion in resected nonsmall cell lung carcinoma: Correlation with TNM stage and disease free and overall survival , 1996, Cancer.

[34]  A. Palotie,et al.  Novel human vascular endothelial growth factor genes VEGF-B and VEGF-C localize to chromosomes 11q13 and 4q34, respectively. , 1996, Circulation.

[35]  J. Folkman.  Angiogenesis in cancer, vascular, rheumatoid and other disease , 1995, Nature Medicine.

[36]  C. Angeletti,et al.  Blood vessel invasion by tumor cells predicts recurrence in completely resected T1 N0 M0 non-small-cell lung cancer. , 1993, The Journal of thoracic and cardiovascular surgery.

[37]  R. Tsuchiya,et al.  Prognosis and survival in resected lung carcinoma based on the new international staging system. , 1988, The Journal of thoracic and cardiovascular surgery.